1 SFL share price target reports by brokerages below. See what is analyst's view on SFL share price forecast, rating, estimates, valuation and prediction behind the target. You may use these research report forecasts for long-term to medium term for your investment or trades in 2020.
Sheela Foam is amongst the top 3 players in the industry and expected to be big beneficiary of the shift in taste following urbanization and changing lifestyle. We observe that shift from unorganized to organized segment is captured largely by economy level mattress whereas superior brands like ‘Sleepwell’ is lagging behind in this transition. Sheela foam has introduced two economy level mattress brands which is leading the volume growth at present. Going forward these brand would face immense pressure from highly competitive industry with very little product differentiation in the given price range.Additionally, e-commerce sales are majorly targeted by startups which are doing pretty well. While SFL’s has witnessed higher volume growth with aggressive A&P spends and sales driven by economy mattresses, the margins have improved on lower RM prices. The management remains confident of recovery in sales, however sales mix may result in marginal improvement blended realizations in mattresses. Factoring in the revenue contribution from Spain subsidiary, continuing benefit of lower RM prices and lower tax rate we have tweaked the estimates marginally upwards. We maintain a BUY with a target of 1553. (32x FY21E EPS of Rs 48.5)
Though margin levers exist, adjusting for the muted outlook in the mattress business we revise down FY20E revenue/EBITDA 3/6%%. However, adjusting for the lower tax rate, we revise PAT up by 3%. We value the standalone business at 40x September 2020E EPS and subsidiaries at 13x September 2020E EPS with revised TP of INR1,489.
E-commerce sales are majorly targeted by startups which are doing pretty well. TDI prices have corrected sharply and full benefits are expected to realize in coming quarter, however, on the backdrop of immense competition in the industry, slowdown observed in non-mattress segment and higher expense on aggressive marketing & sales strategies, we trim our FY20E revenue/PAT estimates by 7%/10% and reduce the rating to HOLD. We roll over EPS to FY21E to arrive at target price of Rs 1236 (~ 35x multiple).
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.